Q32 Bio (QTTB) Debt to Equity (2023 - 2026)
Q32 Bio's quarterly Debt to Equity came in at $0.18 in Q1 2026, up 105.58% year-on-year from $0.09 in Q1 2025, and down 23.58% quarter-over-quarter from $0.23 in Q4 2025.
Q32 Bio has reported Debt to Equity for 4 years, with the latest figure at $0.18 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 105.58% year-over-year to $0.18; the trailing twelve-month figure through Mar 2026 stood at $0.18 (up 105.58% YoY), and the FY2025 full-year result was $0.23, down 89.64% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.18, down from $0.23 in the prior quarter.
- The five-year high for Debt to Equity was $2.23 in Q4 2024, with the low at -$3.16 in Q1 2025.
- Average Debt to Equity over 4 years is -$0.09, with a median of $0.2 recorded in 2025.
- Year-over-year, Debt to Equity surged 7570.99% in 2024 and tumbled 1335.7% in 2025.
- Tracing QTTB's Debt to Equity over 4 years: stood at -$0.03 in 2023, then surged by 7570.99% to $2.23 in 2024, then tumbled by 89.64% to $0.23 in 2025, then fell by 23.58% to $0.18 in 2026.
- The last three Debt to Equity figures came in at $0.18 (Q1 2026), $0.23 (Q4 2025), and -$0.61 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.18 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | -0.61 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -3.16 |
| Dec 31, 2024 | 2.23 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.26 |
| Dec 31, 2023 | -0.03 |